The mission of St. Jude Children’s Research Hospital is to advance cures, and means of prevention, for pediatric catastrophic diseases through research and treatment. Consistent with the vision of our founder Danny Thomas, no child is denied treatment based on race, religion or a family's ability to pay.
Seeking treatment?
Our approach makes us different from most children’s hospitals. Learn more about seeking treatment for your child at St. Jude.
Our history
Founder and entertainer Danny Thomas opened the doors to St. Jude in 1962 with the dream that “no child should die in the dawn of life."
Why support us?
Unlike any other hospital, the majority of our funding comes from individual contributions. And thanks to generous donors, families never receive a bill from St. Jude.
No child should die in the dawn of life.
Cost to family: $0
Families never receive a bill from St. Jude for treatment, travel, housing or food — because all a family should worry about is helping their child live.
Saving kids worldwide
St. Jude has treated children from all 50 states and from around the world.
Our goal: 100% survival
Treatments invented at St. Jude have helped push the overall childhood cancer survival rate from 20% to more than 80% since it opened more than 50 years ago.
Our stories
Meet our patients, families, supporters, and staff and experience the innovative research, pioneering treatments and inspirational stories that happen at St. Jude every day. Experience our stories.
-
Meet Tony
Tony wasn’t quite a year old when his family learned he suffered from ALL, a type of blood cancer. At St. Jude, he began chemotherapy immediately.
-
Meet Myra
Myra was experiencing severe headaches, and it was discovered to be a rare form of lymphoma called primary CNS ALCL.
-
A vintage night in miami for St. Jude
Hundreds of supporters donned '50s-era Miami glamour at the FedEx/ St. Jude Angels and Stars Gala to support the kids of St. Jude.
-
St. Jude hosts family conference on Li-Fraumeni syndrome
View images from the inaugural Cancer Predisposition Family Conference, an event for families living with Li-Fraumeni syndrome.
-
Selfless support
ALSAC President and CEO Richard C. Shadyac Jr. reflects on the hope that supporters gave to St. Jude kids and children around the world in the first half of 2018.
-
What's Your Reason to Walk?
Gratitude is the reason Team Griffin hits the pavement during the St. Jude Walk/Run to End Childhood Cancer.
-
Spurred into Action: Discovering the Origins of Rhabdomyosarcoma
In the race to increase survival rates for the soft-tissue cancer, one researcher proved rhabdomyosarcoma can originate in the inner surface of blood vessels.
-
Saving the World's Most Vulnerable Children
Learn how St. Jude helps save lives for Syrian refugee children with cancer and how international efforts are expanding in Middle East and Mediterranean regions.
-
Reflections on Survivors' Social Connections
Young cancer survivors face unique challenges when it comes to bonding on social media. Learn how a study of these connections is helping inform support plans for patients in treatment.
-
Life After Treatment: My Legacy
A long-term cancer survivor shares his story of St. Jude, how cancer shaped his life, and what his life is like after remission.
-
Partners for HIV Prevention
St. Jude partners with the community to bring cutting-edge HIV prevention and education to at-risk youth.
-
From Student to Scientist: The St. Jude Graduate School of Biomedical Sciences
Receiving dedicated advising and mentorship by world-class biomedical researchers has inspired the inaugural class of the graduate school to become more than just students.
-
Nutritious...Delicious...Nutriolicious!
A fun, informative cooking class offers a delicious smorgasbord of benefits for patients and families.
-
Cloud with a Gold Lining
St. Jude Cloud provides a way for researchers to quickly share information in the world's largest public collection of pediatric cancer genomics data.
-
Medulloblastoma: DNA Points the Way
Find out about how the discovery of 6 inherited gene mutations in medulloblastoma prompted the proposed guidelines for genetic counseling and testing when treating this type of brain cancer.
